Marvel Rivals Season 1.5 is here, arriving with two new characters, a whole bunch of tweaks for the existing roster, and more ...

Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic ...

Session: Poster Session B Abstract title:Combination immunotherapy with an albumin-binding interleukin-12 fusion protein that extends cytokine half-life, targets the tumor microenvironment, and ...

Inhibition of nonsense-mediated decay turns immunologically cold tumors hot by increasing the amount of mutant RNA leading to an increase in T-cell-targetable neoantigens on the cell surface.

Researchers from Haifa have pinpointed the neural pathway linking the brain and immune system, revealing how the placebo ...

Fast-paced lifestyle and modern medicines have weakened the immune system of most people, making them unable to fight ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced that BOT/BAL will be featured in two presentations at the upcoming American Association for Cancer Research (AACR) IO Annual ...

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced plans to showcase updated clinical data on its ...

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with ...

Omeros Corporation (Nasdaq: OMER) today announced two presentations that will be featured at the 2025 Tandem Meetings – the ...

Researchers explore the cellular and molecular adaptations associated with human secondary lymphoid tissue in adults during ...

How the microbes in the human gut play roles in health and disease will be explored in a talk Tuesday, Feb. 11, by Robert "Bob" Hettich, corporate fellow and leader of the Bioanalytical Mass ...